Alta Mesa Holdings, LP Announces Early Participation Time Extension
Feb 26, 2016 13:00 pm UTC| Business
HOUSTON, Feb. 26, 2016 -- Alta Mesa Holdings, LP (“Alta Mesa” or the “Company”) today announced that the Early Participation Time in relation to its private offer to exchange (the “Exchange Offer”) any and all of its...
Pacific Mercantile Bank Announces Senior Management Promotions
Feb 26, 2016 13:00 pm UTC| Business
COSTA MESA, Calif., Feb. 26, 2016 -- Pacific Mercantile Bank (“the Bank”), the wholly owned subsidiary of Pacific Mercantile Bancorp (NASDAQ:PMBC), is pleased to announce the following promotions within its senior...
MB Financial Bank, N.A. Announces Agreement to Sell Its Branch in Seneca, Illinois
Feb 26, 2016 13:00 pm UTC| Business
CHICAGO, Feb. 26, 2016 -- MB Financial, Bank N.A. (“MB”), a wholly owned subsidiary of MB Financial, Inc., announced today an agreement to sell its branch in Seneca, Illinois to First National Bank of Dwight, a wholly...
TPC Group Announces Fourth Quarter 2015 Earnings Call
Feb 26, 2016 13:00 pm UTC| Business
HOUSTON, Feb. 26, 2016 -- TPC Group Inc. announced today that it will post its results for the quarter and year ended December 31, 2015 on its website on Thursday, March 10 at 1 p.m. EST (noon CST) and that it will host...
INTL FCStone Financial Launches Asset-Backed Securities Trading
Feb 26, 2016 13:00 pm UTC| Business
NEW YORK, Feb. 26, 2016 -- INTL FCStone Inc. (NASDAQ:INTL), a diversified global financial services organization delivering execution and advisory services in commodities, currencies and securities, today announced its...
Feb 26, 2016 13:00 pm UTC| Business
Fourth Quarter Highlights: Net income of $5.0 million, or $0.10 per diluted common shareAFFO of $7.0 million, or $0.14 per diluted common share1Recorded gains of $3.8 million from the sales of real estate assetsEarned $1.3...
Chiasma to Report Fourth Quarter and Year End 2015 Financial Results on March 14
Feb 26, 2016 13:00 pm UTC| Business
NEWTON, Mass., Feb. 26, 2016 -- Chiasma, Inc. (NASDAQ:CHMA), a late-stage biopharmaceutical company developing Mycapssa™ (octreotide) capsules, a new investigational oral drug for the potential maintenance therapy of...